With that staying said, without having human trials there is no way to actually evaluate exactly how much YK11 can inhibit Myostatin in humans (if whatsoever), and if there is a dosage that might equate to precisely the same standard of Myostatin inhibition that a genetic anomaly which has a gene mutation has.Analysis has demonstrated that Ligandro